MCL1 and non-Hodgkin lymphoma: 5) PI3Ki has been found synergistic effects with HDACi in vitro and in vivo in non-Hodgkin lymphoma (NHL), via induction of DNA damage, downregulation of Mcl-1, and upregulation of Bim protein [68].